CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 113 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q2 2022. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $263,685 | -18.3% | 12,079 | +19.0% | 0.00% | 0.0% |
| Q2 2023 | $322,796 | +30.3% | 10,154 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $247,656 | -22.7% | 10,154 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $320,257 | +58.5% | 10,154 | +42.3% | 0.00% | +100.0% |
| Q3 2022 | $202,000 | +6.9% | 7,134 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $189,000 | -24.4% | 7,134 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $250,000 | +40.4% | 7,134 | +30.3% | 0.00% | 0.0% |
| Q4 2021 | $178,000 | +102.3% | 5,477 | +82.6% | 0.00% | – |
| Q3 2021 | $88,000 | – | 2,999 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |